Prof. Marco Rusnati | Prof. Pasqualina D’Ursi

Among the various aspects that characterize precision medicine, the high selectivity of the drugs to be developed or already currently used in this biomedical field is particularly important. In turn, the selectivity and specificity of a drug implies its ability to interact with its pathological target (proteins/nucleic acids) with high affinity. These considerations suggest the importance of suitable methodologies for studying biomolecular interactions, which are fundamental for making the “drug discovery” process more efficient. With this in mind, the most recent developments of this type of study in the virtual and experimental fields will be considered in this course.

---